Neurovascular Embolization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$7500
Buy Report Download FREE Resources

Published: June 26, 2026 Report Code: GDME571MM-ST

Select Item

Analyze the global Neurovascular Embolization Devices market through 2036, covering market size, device segments, interventions, pricing, company shares, regulation, reimbursement, and competitive dynamics across 39 countries.

Why Does the Neurovascular Embolization Devices Market Matter?

The global neurovascular embolization devices market is an important segment within neurology devices, supporting minimally invasive treatment of abnormalities in blood vessels in the brain, including brain aneurysms and arteriovenous malformations (AVMs).

This report provides a comprehensive analysis of the Neurovascular Embolization Devices market, combining quantitative market data with qualitative insights across device segments, interventions, pricing, competitive dynamics, healthcare systems, reimbursement, and medtech regulation through 2036.

The market model covers 39 countries and provides fully sourced, color-coded data on market value, volumes, product usage, average selling prices, and company share and rank analysis where available.

You can use this report to:

  • Understand global and country-level Neurovascular Embolization Devices market trends
  • Analyze market size, revenue, unit volumes, and average selling prices through 2036
  • Evaluate demand across key neurovascular embolization device segments
  • Benchmark leading companies and competitive positioning
  • Assess intervention volumes and epidemiology-based indications
  • Understand country-specific reimbursement and regulatory environments
  • Identify emerging opportunities in neurovascular device technologies
  • Support strategic planning, investment, market access, and commercial decisions

Key Insights in the Neurovascular Embolization Devices Market

The report provides detailed analysis of the technologies used to occlude or redirect blood flow in unwanted cerebral vessel malformations.

Key themes covered include:

  • Brain aneurysm and AVM treatment trends
  • Embolization coils
  • Aneurysm clips
  • Liquid embolic systems
  • Flow diversion stents
  • Intrasaccular flow disruptors
  • Intervention volumes
  • Product usage and market values
  • Average selling prices
  • Company market share and rankings
  • Competitive dynamics
  • Regulatory and reimbursement trends

Embolization coils remain the most preferred treatment method for brain aneurysms, followed by aneurysm clips.

Scope

What Will You Learn from This Neurovascular Embolization Devices Market Report?

This report provides insight into:

  • Global Neurovascular Embolization Devices market revenue from 2015 to 2036

  • Regional and country-level market performance

  • Market size and forecasts by device segment

  • Unit and intervention volumes

  • Product usage trends

  • Average selling prices

  • Company share and ranking analysis

  • Key industry trends

  • SWOT analysis

  • Competitive dynamics

  • Healthcare system structures

  • Reimbursement policies

  • Country-specific medtech regulations

  • Epidemiology-based indications and intervention volumes

The interactive Excel model enables users to evaluate market performance through quantitative data alongside analyst commentary that provides context for market developments.

Target Buyers for This Neurovascular Embolization Devices Market Model

This report may be valuable for:

  • Medical device manufacturers

  • Neurovascular device companies

  • CMO executives

  • Sourcing and procurement executives

  • Healthcare investors

  • Private equity firms

  • Market intelligence teams

  • Commercial strategy teams

  • Regulatory and market access professionals

  • Healthcare consultants and advisors

How Companies Use This Neurovascular Embolization Devices Market Analysis

Medical device manufacturers can use the model to assess market growth, competitor positioning, product usage, and future demand.

Sourcing and procurement executives can evaluate the competitive supply landscape and understand key companies operating across the market.

Private equity investors can use market size, growth, company share, pricing, and competitive data to identify and assess potential investment opportunities.

Commercial teams can identify high-growth market segments and countries to prioritize sales and marketing efforts.

Regulatory and market access teams can evaluate country-specific reimbursement and medtech regulatory environments when developing market entry strategies.

Reasons to Buy

Benchmark Neurovascular Embolization Device Companies and Markets

The report helps stakeholders benchmark:

  • Market revenue

  • Unit volumes

  • Intervention volumes

  • Average selling prices

  • Product usage

  • Company share

  • Company rankings

  • Competitive dynamics

  • Regulatory environments

  • Reimbursement policies

By comparing these factors across markets, organizations can identify high-potential opportunities and better understand the factors influencing neurovascular device adoption.

Develop Strategic Opportunities in the Neurovascular Embolization Devices Market

The report can support strategic decision-making across licensing, investment, commercial expansion, and competitive planning.

Stakeholders can use the analysis to:

  • Develop in-licensing and out-licensing strategies

  • Identify key companies and emerging players

  • Evaluate market segments with strong growth potential

  • Understand trends shaping neurovascular device demand

  • Assess innovative technologies and product developments

  • Formulate sales and marketing strategies

  • Develop competitive counter-strategies

  • Identify opportunities for consolidation and investment

  • Evaluate potential strategic partnerships

  • Track device sales from 2015 to 2036

Built on GlobalData Medtech Intelligence

GlobalData’s Neurovascular Embolization Devices Market Model combines quantitative market modeling, primary research, real-world data, and analyst expertise to provide a detailed view of the global neurovascular devices landscape.

The model delivers market intelligence across 39 countries and provides the data and strategic context needed to understand market evolution, competitive positioning, market access, and future opportunities through 2036.

Medtronic Plc
Stryker Corp
Terumo Neuro
Cerenovus
Integra LifeSciences Corp
Penumbra Inc
MicroPort Scientific Corp
Balt SAS
B. Braun Melsungen AG
Phenox GmbH
Others
Neurovascular Embolization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 standard reports
Currency USD
$7,500

Can be used by individual purchaser only

Most Popular
$15,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Neurovascular Embolization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Neurology Devices reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Neurovascular Embolization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 in real time.

  • Access a live Neurovascular Embolization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more